PeerView Gastroenterology CME/CNE/CPE Audio Podcast-logo

PeerView Gastroenterology CME/CNE/CPE Audio Podcast

Education Podcasts >

PeerView is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerView is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerView is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Mark S. Sulkowski, MD - Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

1/14/2019
More
Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Duration:01:23:27

Jorge A. Marrero, MD, MS - Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes

1/11/2019
More
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes

Duration:01:32:05

Johanna C. Bendell, MD - Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management

7/18/2018
More
Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management

Duration:01:06:44

George D. Demetri, MD - Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors

7/13/2018
More
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors

Duration:01:10:43

Prof Eric Van Cutsem, MD, PhD - The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors

7/11/2018
More
The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors

Duration:01:06:38

Fernando J. Martinez, MD, MS - Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego

7/4/2018
More
Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego

Duration:00:25:54

Gayle Jameson, MSN, ACNP-BC, AOCN - The Pancreatic Cancer Journey: Oncology Nurses Paving the Path to Patient-Centric Care

6/26/2018
More
The Pancreatic Cancer Journey: Oncology Nurses Paving the Path to Patient-Centric Care

Duration:01:06:09

Richard Kim, MD - A Team Approach to Tackling the Complexities in Later Lines of Therapy for Metastatic Colorectal Cancer

6/4/2018
More
A Team Approach to Tackling the Complexities in Later Lines of Therapy for Metastatic Colorectal Cancer

Duration:00:35:39

Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment

5/28/2018
More
At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment

Duration:00:57:18

Ira M. Jacobson, MD - HCV From Screening to Cure: A Closer Look at Changing At-Risk Populations and an Evolving Treatment Landscape

5/22/2018
More
HCV From Screening to Cure: A Closer Look at Changing At-Risk Populations and an Evolving Treatment Landscape

Duration:00:37:34

Ghassan Abou-Alfa, MD, MBA - Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches

5/2/2018
More
Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches

Duration:00:37:17

Andrew H. Ko, MD - The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches

4/18/2018
More
The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches

Duration:01:19:13

Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?

4/13/2018
More
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?

Duration:01:21:01

Naiyer Rizvi, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

4/4/2018
More
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

Duration:01:18:45

Robin L. Jones, MD - Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

12/15/2017
More
Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

Duration:01:14:42

David L. Rimm, MD, PhD - The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

12/13/2017
More
The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

Duration:01:14:37

Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances

12/8/2017
More
The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances

Duration:01:07:21

Stanley Cohen, MD - A Biosimilars Primer for Managed Care

10/13/2017
More
A Biosimilars Primer for Managed Care

Duration:00:20:34

Mark S. Sulkowski, MD - Emerging Issues and Challenges for Improving HCV Patient Care: Expert Perspectives on the Importance of Interdisciplinary Collaboration

8/16/2017
More
Emerging Issues and Challenges for Improving HCV Patient Care: Expert Perspectives on the Importance of Interdisciplinary Collaboration

Duration:00:55:59

Anthony El-Khoueiry, MD - Looking to the Future in Hepatocellular Carcinoma: A Master Class on Current and Emerging Therapeutic Strategies

7/21/2017
More
Looking to the Future in Hepatocellular Carcinoma: A Master Class on Current and Emerging Therapeutic Strategies

Duration:01:25:54